SCHEMBL15904234

SCHEMBL15904234

O=Cc1cc(F)cc(F)c1Oc1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 2/20 0.46
▸ PTGDR2 Q9Y5Y4 2/20 0.42
▸ PNLIP P16233 2/20 0.40
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ EPAS1 Q99814 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ LMNA P02545 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CASP6 P55212 1/20 0.35
▸ S1PR3 Q99500 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14662607 0.88 SOS1 (0.44) ERN1PTGDR2PNLIPEPAS1TDP1
SCHEMBL15904298 0.86 ERN1 (0.47) ERN1EPAS1LMNAHTR2ASLC6A4
SCHEMBL14662075 0.85 ALDH1A1 (0.42) ERN1EPAS1TDP1CYP1A2CYP3A4
SCHEMBL15904100 0.84 ERN1 (0.42) ERN1EPAS1TDP1LMNACYP1A2
SCHEMBL14662732 0.82 ERN1 (0.48) ERN1EPAS1
SCHEMBL15904179 0.80 PPARG (0.43) ERN1CYP1A2CYP3A4CYP2C9PPARG
SCHEMBL31276674 0.79 PLA2G7 (0.44) PPARG
SCHEMBL15904561 0.79 HSD17B10 (0.45) PTGDR2LMNACYP1A2CYP2C9CYP2C19
SCHEMBL5175967 0.77 SOS1 (0.44) ERN1TDP1CYP1A2CYP2C9CYP2C19
SCHEMBL24512757 0.76 TDP1 (0.44) ERN1TDP1SMN1; SMN2POLBCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2948456-A1 BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2 GlaxoSmithKline Intellectual Property Development Limited (GB) 2015-12-02 — — EP disclosed
WO-2014114249-A1 BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2014-07-31 — — WO disclosed
Send feedback